COMPUTATIONAL ONCOLOGY RESEARCH INITIATIVE

CURE FOR CANCER BY CLAUDE

Leveraging Anthropic's Claude Opus and open-source genomic databases to accelerate computational cancer research. AI-powered analysis at unprecedented scale.

BUY THE TOKEN → VIEW OUR PIPELINE
CLAUDE OPUS 4  •  GENOMIC SEQUENCING  •  OPEN-SOURCE DATASETS  •  PROTEIN FOLDING  •  MOLECULAR DYNAMICS  •  TCGA DATABASE  •  SINGLE-CELL RNA-SEQ  •  IMMUNOTHERAPY MODELING  •  DRUG DISCOVERY  •  BIOMARKER IDENTIFICATION  •  COMPUTATIONAL PATHOLOGY  •  CLAUDE OPUS 4  •  GENOMIC SEQUENCING  •  OPEN-SOURCE DATASETS  •  PROTEIN FOLDING  •  MOLECULAR DYNAMICS  •  TCGA DATABASE  •  SINGLE-CELL RNA-SEQ  •  IMMUNOTHERAPY MODELING  •  DRUG DISCOVERY  •  BIOMARKER IDENTIFICATION  •  COMPUTATIONAL PATHOLOGY  • 
001 — THE MISSION

AI doesn't sleep.
Cancer shouldn't
either.

We're pairing Claude Opus — one of the most capable AI systems ever built — with the world's largest open-source cancer research databases to find patterns humans can't see. Every dollar funds compute cycles that could unlock the next breakthrough.

[PLACEHOLDER: Detailed mission statement, founder story, and organizational background. Include specific cancer types being targeted and research partnerships.]

01

Ingest Open-Source Data

TCGA, GEO, COSMIC, cBioPortal — millions of genomic profiles fed into Claude for pattern analysis.

02

AI-Powered Analysis

Claude Opus processes multi-modal data across genomics, proteomics, and clinical records simultaneously.

03

Publish & Accelerate

Findings shared open-source with research institutions worldwide. No paywalls. No gatekeeping.

002 — RESEARCH VECTORS

Active Research Areas

Each research vector is powered by Claude Opus analyzing terabytes of open-source oncology data.

Genomic Pattern Recognition

Using Claude to identify mutation signatures across 11,000+ tumor samples from TCGA that correlate with treatment response.

ACTIVE — 847 COMPUTE HOURS

Drug Interaction Modeling

AI-driven molecular simulation to predict novel drug combinations for resistant cancer phenotypes. Open-source compound libraries.

ACTIVE — 523 COMPUTE HOURS

Immunotherapy Optimization

Predicting patient-specific immunotherapy responses using single-cell RNA sequencing data analyzed at scale by Claude.

ACTIVE — 691 COMPUTE HOURS
003 — THE PIPELINE

How Your Dollar
Becomes a Discovery

PHASE 01 — DATA INGESTION

Open-Source Database Aggregation

We pull from TCGA, GEO, COSMIC, ICGC, cBioPortal, and 20+ other open-source genomic databases. Structured, cleaned, and formatted for AI consumption. [PLACEHOLDER: Specific data pipeline details]

PHASE 02 — AI ANALYSIS

Claude Opus Computational Processing

Multi-modal analysis across genomics, proteomics, metabolomics, and clinical outcome data. Pattern recognition at a scale impossible for human researchers alone. [PLACEHOLDER: Technical methodology details]

PHASE 03 — PUBLICATION

Open-Source Results & Collaboration

All findings published to open repositories. Partner institutions validate and extend our AI-generated hypotheses in wet labs. [PLACEHOLDER: Partner institution names and publication strategy]

004 — IMPACT

By The Numbers

$0
RAISED SO FAR
[PLACEHOLDER]
0
COMPUTE HOURS
[PLACEHOLDER]
0
DATASETS ANALYZED
[PLACEHOLDER]
0
RESEARCH PARTNERS
[PLACEHOLDER]